Diligence memo · auto-generated · as of July 2, 2026

Altus Radiation Oncology (Beaumont), L.P.

Altus Radiation Oncology (Beaumont), L.P. looks under-valued against its niche peers and is active on financing cadence.

SourceModeled below same-niche peers while still financing on rhythm — a potential mispricing worth a closer look.

Businessfiled

Altus Radiation Oncology (Beaumont), L.P. operates in Other Health Care, based in Pearland.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Altus Radiation Oncology (Beaumont), L.P. has raised $1.5M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $750K on —.

Valuation (modeled)modeled

Provath models Altus Radiation Oncology (Beaumont), L.P. at approximately $1.2M (range $470K–$2.2M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.19× the median modeled value of Pre-Seed Other Health Care companies (2036 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

No dated round to assess.

The last round stepped up 1.0× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 41% of Other Health Care peers (5377 compared).

Modeled value ranks above 7% of those peers.

Peoplefiled

2 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.